We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · September 20, 2020

Comparative Risk of Lymphoma With Anti-TNF Agents and/or Thiopurines in IBD

Alimentary Pharmacology & Therapeutics


Additional Info

Disclosure statements are available on the authors' profiles:

Alimentary Pharmacology & Therapeutics
Systematic Review With Meta-Analysis: Comparative Risk of Lymphoma With Anti-Tumour Necrosis Factor Agents and/or Thiopurines in Patients With Inflammatory Bowel Disease
Aliment. Pharmacol. Ther. 2020 Aug 25;[EPub Ahead of Print], A Chupin, V Perduca, A Meyer, C Bellanger, F Carbonnel, C Dong

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading